Evidence map›Paper›PMID 34522000›Full record

ArticleCommunications biology2021

HA-MOP knockin mice express the canonical µ-opioid receptor but lack detectable splice variants.

Sebastian Fritzwanker, Lionel Moulédous, Catherine Mollereau, Carine Froment, Odile Burlet-Schiltz, Felix Effah, Alexis Bailey, Mariana Spetea, Rainer K Reinscheid, Stefan Schulz and 1 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Generation of Flag/DYKDDDDK Epitope Tag Knock-In Mice UsingInternational journal of molecular sciences · 2022
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Sebastian FritzwankerDepartment of Pharmacology and Toxicology, Jena University Hospital-Friedrich Schiller University Jena, Jena, Germany.
Lionel MoulédousResearch Center on Animal Cognition, Center for Integrative Biology, CNRS, UPS, Toulouse University, Toulouse, France.ORCID 0000-0002-7675-3493
Catherine MollereauResearch Center on Animal Cognition, Center for Integrative Biology, CNRS, UPS, Toulouse University, Toulouse, France.ORCID 0000-0003-1543-5624
Carine FromentInstitut de Pharmacologie et de Biologie Structurale (IPBS), CNRS, UPS, Université de Toulouse, Toulouse, France.
Odile Burlet-SchiltzInstitut de Pharmacologie et de Biologie Structurale (IPBS), CNRS, UPS, Université de Toulouse, Toulouse, France.
Felix EffahPharmacology Section, St George's University of London, London, UK.ORCID 0000-0001-5623-914X
Alexis BaileyPharmacology Section, St George's University of London, London, UK.ORCID 0000-0003-1541-1964
Mariana SpeteaDepartment of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria.
Rainer K ReinscheidDepartment of Pharmacology and Toxicology, Jena University Hospital-Friedrich Schiller University Jena, Jena, Germany.
Stefan SchulzDepartment of Pharmacology and Toxicology, Jena University Hospital-Friedrich Schiller University Jena, Jena, Germany. stefan.schulz@med.uni-jena.de.ORCID 0000-0002-5997-8885
Andrea KliewerDepartment of Pharmacology and Toxicology, Jena University Hospital-Friedrich Schiller University Jena, Jena, Germany. andrea.kliewer@med.uni-jena.de.ORCID 0000-0002-1320-6505
Centre National de la Recherche Scientifique · FRJena University Hospital · DESt George's, University of London · GBUniversität Innsbruck · AT

Funding

Austrian Science Fund FWF I 2463Deutsche Forschungsgemeinschaft (German Research Foundation) SCHU924/18-1Deutsche Forschungsgemeinschaft (German Research Foundation) SFB/TR166-TPC5
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are notoriously difficult to detect in native tissues. In an effort to resolve this problem, we have developed a novel mouse model by fusing the hemagglutinin (HA)-epitope tag sequence to the amino-terminus of the µ-opioid receptor (MOP). Although HA-MOP knock-in mice exhibit reduced receptor expression, we found that this approach allowed for highly efficient immunodetection of low abundant GPCR targets. We also show that the HA-tag facilitates both high-resolution imaging and immunoisolation of MOP. Mass spectrometry (MS) confirmed post-translational modifications, most notably agonist-selective phosphorylation of carboxyl-terminal serine and threonine residues. MS also unequivocally identified the carboxyl-terminal

Indexed as

Amino Acid SequenceAnimalsFemaleHemagglutininsMaleMicePhosphorylationProtein IsoformsReceptors, Opioid, muHemagglutininsOprm protein, mouseProtein IsoformsReceptors, Opioid, mu

Identifiers

PMID34522000
PMCPMC8440528
OpenAlexW3112964454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.